Impact of Lymph Node Ratio on Survival in Papillary Thyroid Cancer

被引:128
作者
Schneider, David F. [1 ]
Chen, Herbert [1 ]
Sippel, Rebecca S. [1 ]
机构
[1] Univ Wisconsin, Dept Surg, Sect Endocrine Surg, Madison, WI 53706 USA
关键词
CENTRAL NECK DISSECTION; THYROGLOBULIN LEVELS; CARCINOMA; METASTASIS; THERAPY;
D O I
10.1245/s10434-012-2802-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In papillary thyroid cancer, the role of lymph node dissection remains controversial, and staging systems consider metastatic lymph nodes as a binary entity. The purpose of this study was to determine a threshold lymph node ratio (LNR) that impacted disease-specific mortality (DSM). We utilized the surveillance, epidemiology, and end results (SEER) database to analyze adult patients who underwent thyroidectomy with lymph node dissection. A LNR (metastatic lymph nodes to total lymph nodes) was calculated after eliminating patients with less than three nodes collected. Kaplan-Meier estimates for DSM were plotted for LNRs and compared by the log rank test. The Cox proportional hazards model was used to evaluate LNR with other known clinical and pathologic determinants of prognosis. A total of 10,955 cases contained data on lymph nodes. Median follow-up time was 25 months (range 0-59 months), and the mean LNR was 0.28 +/- A 0.37. After comparing Kaplan-Meier survival estimates and overall DSM rates, we found that a LNR a parts per thousand yen0.42 best divided those with lymph node metastasis based on DSM (p < 0.01). Those with a LNR a parts per thousand yen0.42 experienced a DSM rate of 1.72 % while those with a LNR < 0.42 had a DSM rate of 0.65 % (p < 0.01). In addition, patients with a LNR a parts per thousand yen0.42 experienced a 77 % higher DSM rate compared to those with metastatic lymph nodes as a whole. When considered with other known determinants of prognosis, we found that LNR was strongly associated with DSM (hazard ratio 4.33, 95 % confidence interval 1.68-11.18, p < 0.01). LNR is a strong determinant of DSM, and a threshold LNR of 0.42 can be used to risk-stratify patients with metastatic lymph nodes.
引用
收藏
页码:1906 / 1911
页数:6
相关论文
共 26 条
  • [11] Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO
  • [12] 2-1
  • [13] Significance of Metastatic Lymph Node Ratio on Stimulated Thyroglobulin Levels in Papillary Thyroid Carcinoma after Prophylactic Unilateral Central Neck Dissection
    Lang, Brian Hung-Hin
    Wong, Kai Pun
    Wan, Koon Yat
    Lo, Chung-Yau
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (04) : 1257 - 1263
  • [14] LONG-TERM IMPACT OF INITIAL SURGICAL AND MEDICAL THERAPY ON PAPILLARY AND FOLLICULAR THYROID-CANCER
    MAZZAFERRI, EL
    JHIANG, SM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1994, 97 (05) : 418 - 428
  • [15] PAPILLARY THYROID-CARCINOMA - IMPACT OF THERAPY IN 576 PATIENTS
    MAZZAFERRI, EL
    YOUNG, RL
    OERTEL, JE
    KEMMERER, WT
    PAGE, CP
    [J]. MEDICINE, 1977, 56 (03) : 171 - 196
  • [16] The Pros and Cons of Prophylactic Central Compartment Lymph Node Dissection for Papillary Thyroid Carcinoma
    Mazzaferri, Ernest L.
    Doherty, Gerard M.
    Steward, David L.
    [J]. THYROID, 2009, 19 (07) : 683 - 689
  • [17] Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: A population-based study of 8,177 cases
    Mocellin, Simone
    Pasquali, Sandro
    Rossi, Carlo Riccardo
    Nitti, Donato
    [J]. SURGERY, 2011, 150 (01) : 83 - 90
  • [18] NOGUCHI S, 1970, CANCER, V26, P1053, DOI 10.1002/1097-0142(197011)26:5<1053::AID-CNCR2820260513>3.0.CO
  • [19] 2-X
  • [20] Podnos YD, 2005, AM SURGEON, V71, P731